These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 30335466)

  • 1. Moving toward Tuberculosis Elimination. Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection.
    Keshavjee S; Amanullah F; Cattamanchi A; Chaisson R; Dobos KM; Fox GJ; Gendelman HE; Gordon R; Hesseling A; Le Van H; Kampmann B; Kana B; Khuller G; Lewinsohn DM; Lewinsohn DA; Lin PL; Lu LL; Maartens G; Owen A; Protopopova M; Rengarajan J; Rubin E; Salgame P; Schurr E; Seddon JA; Swindells S; Tobin DM; Udwadia Z; Walzl G; Srinivasan S; Rustomjee R; Nahid P
    Am J Respir Crit Care Med; 2019 Mar; 199(5):564-571. PubMed ID: 30335466
    [No Abstract]   [Full Text] [Related]  

  • 2. Policy Implications of Mathematical Modeling of Latent Tuberculosis Infection Testing and Treatment Strategies to Accelerate Tuberculosis Elimination.
    Marks SM; Dowdy DW; Menzies NA; Shete PB; Salomon JA; Parriott A; Shrestha S; Flood J; Hill AN
    Public Health Rep; 2020; 135(1_suppl):38S-43S. PubMed ID: 32735183
    [No Abstract]   [Full Text] [Related]  

  • 3. Predicting progression to active tuberculosis: A rate-limiting step on the path to elimination.
    Lalvani A; Berrocal-Almanza LC; Halliday A
    PLoS Med; 2019 May; 16(5):e1002814. PubMed ID: 31125334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination.
    Diel R; Loddenkemper R; Zellweger JP; Sotgiu G; D'Ambrosio L; Centis R; van der Werf MJ; Dara M; Detjen A; Gondrie P; Reichman L; Blasi F; Migliori GB;
    Eur Respir J; 2013 Sep; 42(3):785-801. PubMed ID: 23397299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Specific features of tuberculosis in childhood].
    Delacourt C
    Rev Mal Respir; 2011 Apr; 28(4):529-41. PubMed ID: 21549907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis Elimination, Research, and Respect for Persons.
    Schluger NW
    Am J Respir Crit Care Med; 2019 Mar; 199(5):560-563. PubMed ID: 30339459
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnosis and treatment of latent infection with Mycobacterium tuberculosis.
    Chee CB; Sester M; Zhang W; Lange C
    Respirology; 2013 Feb; 18(2):205-16. PubMed ID: 23107218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Contact tracing and prophylaxis of tuberculosis].
    Seersholm N; Wilcke T
    Ugeskr Laeger; 2011 Mar; 173(12):883-6. PubMed ID: 21419057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translational Research for Tuberculosis Elimination: Priorities, Challenges, and Actions.
    Lienhardt C; Lönnroth K; Menzies D; Balasegaram M; Chakaya J; Cobelens F; Cohn J; Denkinger CM; Evans TG; Källenius G; Kaplan G; Kumar AM; Matthiessen L; Mgone CS; Mizrahi V; Mukadi YD; Nguyen VN; Nordström A; Sizemore CF; Spigelman M; Squire SB; Swaminathan S; Van Helden PD; Zumla A; Weyer K; Weil D; Raviglione M
    PLoS Med; 2016 Mar; 13(3):e1001965. PubMed ID: 26933883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlling latent TB tuberculosis infection in high-burden countries: A neglected strategy to end TB.
    Churchyard GJ; Swindells S
    PLoS Med; 2019 Apr; 16(4):e1002787. PubMed ID: 31013273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis elimination, patients' lives and rational use of new drugs: revisited.
    Tiberi S; D'Ambrosio L; De Lorenzo S; Viggiani P; Centis R; Migliori GB
    Eur Respir J; 2016 Feb; 47(2):664-7. PubMed ID: 26541536
    [No Abstract]   [Full Text] [Related]  

  • 12. Prospects for tuberculosis elimination.
    Dye C; Glaziou P; Floyd K; Raviglione M
    Annu Rev Public Health; 2013; 34():271-86. PubMed ID: 23244049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing tuberculosis in children: A global health emergency.
    Reuter A; Seddon JA; Marais BJ; Furin J
    Paediatr Respir Rev; 2020 Nov; 36():44-51. PubMed ID: 32253128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterium tuberculosis strain 18b, a useful non-virulent streptomycin dependent mutant to study latent tuberculosis as well as for in vivo and in vitro testing of anti-tuberculosis drugs.
    Campos-Neto A
    Tuberculosis (Edinb); 2016 Jul; 99():54-55. PubMed ID: 27450005
    [No Abstract]   [Full Text] [Related]  

  • 15. Pulmonary tuberculosis: Improving diagnosis and management.
    Singer-Leshinsky S
    JAAPA; 2016 Feb; 29(2):20-5. PubMed ID: 26757063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactive fibrotic lesions versus pulmonary tuberculosis with negative bacteriology.
    Solsona Peiró J; de Souza Galvão ML; Altet Gómez MN
    Arch Bronconeumol; 2014 Nov; 50(11):484-9. PubMed ID: 24713269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug resistance and tuberculosis elimination in low-incidence countries.
    Falzon D; Zellweger JP; Migliori GB; Jaramillo E
    Eur Respir J; 2014 Dec; 44(6):1408-11. PubMed ID: 25435527
    [No Abstract]   [Full Text] [Related]  

  • 18. Tuberculosis: novel approaches to an old disease.
    Fadda G
    J Infect Dev Ctries; 2012 Jan; 6(1):4-5. PubMed ID: 22240420
    [No Abstract]   [Full Text] [Related]  

  • 19. The worldwide epidemic of multidrug-resistant tuberculosis.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2011 May; 11(5):333. PubMed ID: 21530885
    [No Abstract]   [Full Text] [Related]  

  • 20. Some progress and some missed targets in the TB epidemic.
    Tanne JH
    BMJ; 2014 Apr; 348():g2626. PubMed ID: 24740907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.